Global scientists are stepping up research on COVID-19, as the World Health Organization (WHO) moves to advance its scientific collaboration and study of emerging changes of SARS- CoV-2, the virus that causes COVID-19.
A meaningful all-day meeting of scientists from around the world, convened by WHO, brought together more than 1 750 experts from 124 countries to discuss critical information gaps and research priorities for emerging variants of the virus.
Welcoming them, Dr Tedros Adhanom Ghebreyesus, WHO Director General, said: “Science and research have been instrumental in responding to the pandemic from day one and will continue to be at the heart. the heart of everything WHO does. ”
The consultation was structured around six thematic areas covering epidemiology and mathematical modeling, evolutionary biology, animal models, assessments and diagnoses, clinical and therapeutic management and vaccines.
Scientists noted the importance of research for early detection and understanding of the potential impact of emerging variables on diagnosis, treatments, and vaccines.
There was consensus on the importance of bringing the new SARS-CoV-2 research into the global research and innovation agenda while strengthening coordination across subjects.
“Our overall goal is to be at the forefront of the game and to have global equipment to identify and analyze a variety of concerns and understand their implications for disease control efforts,” said Dr. Ana Maria Henao Restrepo , Head of WHO Blueprint R&D.
It is normal for viruses to circulate, but the more the SARS-CoV-2 virus spreads, the more likely it is to change. High transmission rates mean that we should expect more changes.
Of the major changes reported so far, some are related to an increase in transmission but not to the severity of disease. Research is underway to address whether the changes affect public health devices and measures.
Genomic sequencing has been crucial in identifying and responding to new changes.
“So far a staggering 350 000 sets have been shared publicly, but most come from just a few countries. Close monitoring of the series is essential so that the world can keep an eye on changes in the virus, ”said Dr Maria Van Kerkhove, WHO Technical Director of COVID-19.
Increasing the capacity of series worldwide is a priority research area for WHO.
The rapid distribution of virus and serum samples through globally agreed mechanisms requires better laboratory analysis and the ability to monitor layers of concern so that a diagnostic study can be initiated quickly. each time.
Scientists highlighted the importance of national data platforms for recording clinical, epidemiological and virus data that enable the detection and evaluation of new SARS-CoV-2 mutations